Tag: Ongoing
Global Plasma Medicine Markets, Strategies and Implementation Report 2022: A Multidimensional View of the Strategic Evolution of the Ongoing Plasma Medicine Initiatives
DUBLIN, May 05, 2022–(BUSINESS WIRE)–The “Plasma Medicine Market – Strategies and Implementation” report has been added to ResearchAndMarkets.com’s offering. This strategic report provides a multidimensional view of the strategic evolution of the ongoing plasma medicine initiatives. The purpose of the study is to gain a holistic view of the active plasma medicine projects implemented in
Start-up packages and ongoing gender bias in academic medicine
Women in STEM professions have long been told that we’ll achieve gender equity as soon as enough of us join a particular field. That turns out to be false. There are already fields where half of the scientists are women and little has changed in them. Why? I believe that specific decision-making behaviors cumulatively add
Editas Medicine Announces Positive Initial Clinical Data from Ongoing Phase 1/2 BRILLIANCE Clinical Trial of EDIT-101 for LCA10
No serious adverse events or dose-limiting toxicities observed to date Efficacy signals in the mid-dose cohort provide initial support for clinical benefits Treatment in the adult high-dose cohort continues and pediatric mid-dose cohort commencing Data presented in an oral presentation at the International Symposium on Retinal Degeneration Company to host a webcast today at 11:00